Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27251170

Treatment and overall survival in renal cell carcinoma: a Swedish population-based study (2000―2008)

Author
WAHLGREN, T1 ; HARMENBERG, U2 ; SANDSTRÖM, P2 ; LUNDSTAM, S3 ; KOWALSKI, J4 ; JAKOBSSON, M1 ; SANDIN, R1 ; LJUNGBERG, B5
[1] Pfizer AB, Vetenskapsvägen 10, Sollentuna 191 90, Sweden
[2] Department of Oncology-Pathology, Karolinska University Hospital and Karolinska Institutet, Solna, Stockholm 171 76, Sweden
[3] Department of Urology, Sahlgrenska University Hospital, and the Sahlgrenska Academy, University of Gothenburg, Gothenburg 41345, Sweden
[4] JK Biostatistics AB, Luxgatan 23, Stockholm 112 62, Sweden
[5] Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå 901 85, Sweden
Source

British journal of cancer. 2013, Vol 108, Num 7, pp 1541-1549, 9 p ; ref : 3/4 p

CODEN
BJCAAI
ISSN
0007-0920
Scientific domain
Medical oncology
Publisher
Nature Publishing Group, Basingstoke
Publication country
United Kingdom
Document type
Article
Language
English
Author keyword
Sweden metastatic renal cell carcinoma sunitinib survival tyrosine kinase inhibitor
Keyword (fr)
2000 2008 Antiangiogénique Anticancéreux Cancer rein Cancérologie Carcinome Etude statistique Homme Hypernéphrome Inhibiteur de la tyrosine kinase Métastase Santé publique Stade avancé Sunitinib Survie Traitement Suède Cancer Enzyme Inhibiteur enzyme Inhibiteur multikinase Pathologie de l'appareil urinaire Pathologie du rein Protein-tyrosine kinase Transferases Tumeur maligne Europe
Keyword (en)
2000 2008 Antiangiogenic agent Antineoplastic agent Kidney cancer Cancerology Carcinoma Statistical study Human Grawitz tumor Tyrosine kinase inhibitor Metastasis Public health Advanced stage Sunitinib Survival Treatment Sweden Cancer Enzyme Enzyme inhibitor Multikinase inhibitor Urinary system disease Kidney disease Protein-tyrosine kinase Transferases Malignant tumor Europe
Keyword (es)
2000 2008 Antiangiogenico Anticanceroso Cáncer del riñón Cancerología Carcinoma Estudio estadístico Hombre Hipernefroma Inhibidor tyrosine kinase Metástasis Salud pública Estadio avanzado Sunitinib Sobrevivencia Tratamiento Suecia Cáncer Enzima Inhibidor enzima inhibidor multicinasa Aparato urinario patología Riñón patología Protein-tyrosine kinase Transferases Tumor maligno Europa
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B04 Tumors / 002B04C Multiple tumors. Solid tumors. Tumors in childhood (general aspects)

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B14 Nephrology. Urinary tract diseases / 002B14D Tumors of the urinary system / 002B14D01 Kidneys

Discipline
Nephrology. Urinary tract diseases Tumours
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
27251170

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web